Denver Novis Health Shows How to Reverse Type 2
Diabetes Evidence-Based Method
A large 2010 study, titled the DECODE study showed that over 90% of
people in the US that deal with either Type 2 Diabetes or Pre- Diabetes will
experience some form of complication in their lifetime.
Although Diabetes treatment and complication
management are some of the largest expenses for
our healthcare system.
A growing body of knowledge is now helping us understand why the
cookie-cutter treatment approach to diabetes which offers a blood
sugar suppressive drug at each stage of the progression is so ill-
equipped to deliver long-term success.
To date, autoantibody testing and age-to-onset
assessments as well as BMI, HbA1c, insulin resistance,
and insulin secretion measures have been utilized to
categorize individuals into five subtypes [1-3]: ?SAID -
severe autoimmune diabetes ?SIDD - severe insulin-
deficient diabetes ?MOD - maturity-ons
After the initiation of the insulin resistance the
disease becomes increasingly complex as
patients develop diabetes due to a combination
of factors that lead to different pathological
pathways which place them on a diabetic
Specific causes of insulin resistance that results in these subtypes include chronic, low-grade
tissue inflammation, the the deleterious activity of proinflammatory macrophages, immune cell-
mediated inflammation, dyslipidemia, hypothyroidism, and age, among many others [1-6].
Accordingly, the diversity underlying the
varying mechanisms and progression of
type-2 diabetes subtypes warrant
different, functional approaches to
To date, the shift toward more personalized
medicine has become increasingly common in
cancer treatment, but has not reached the level of
evidence- and patient-centered treatment for type 2
diabetes or its subtypes.
Anti-inflammatory therapy may be particularly effective for subgroups of
patients with type 2 diabetes who demonstrate extensive characteristics of
inflammation-induced insulin resistance.
For some patients, the com